Related Experiment Video
Updated: Aug 7, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Urinary excretion of deoxypyridinoline in Perthes' disease: a prospective, controlled comparative study in 83
B Westhoff1, R Krauspe, A E Kalke
1Department of Orthopaedics, Heinrich-Heine-University, Moorenstrasse 5, D-40225, Dusseldorf, Germany. westhoff@med.uni-duesseldorf.de
Insights
Urinary deoxypyridinoline (DPD) levels are reduced in early Perthes' disease, indicating lower bone turnover. These levels may help monitor the disease
Area of Science:
- Orthopedics
- Biochemistry
- Pediatric Endocrinology
Background:
- Perthes' disease is a hip disorder affecting children.
- Bone resorption markers are crucial for understanding bone metabolism in pediatric conditions.
- Deoxypyridinoline (DPD) is a validated marker for bone resorption.
Purpose of the Study:
- To investigate the relationship between urinary deoxypyridinoline (DPD) excretion and Perthes' disease.
- To assess DPD as a potential biomarker for monitoring disease progression and bone turnover in Perthes' disease.
Main Methods:
- Collected first-morning urine samples from 39 children with active Perthes' disease and 44 healthy controls.
- Analyzed urinary DPD levels using chemiluminescence immunoassay.
- Correlated DPD levels with radiological staging (Waldenström, Catterall, Herring) and DPD/creatinine (CREA) ratio.
Main Results:
- Median urinary DPD/CREA ratio was significantly reduced in the condensation stage of Perthes' disease compared to controls (p < 0.0001).
- DPD/CREA ratios showed a trend towards elevated values in the final disease stage (p = 0.05).
- Herring-C patients exhibited significantly lower DPD/CREA ratios than Herring-B patients (p = 0.03).
Conclusions:
- Significantly decreased urinary DPD/CREA ratios in early Perthes' disease suggest reduced bone turnover.
- Findings support a potential systemic etiology for Perthes' disease.
- Urinary DPD levels may serve as a valuable tool for monitoring the course of Perthes' disease.
Abstract:
Our aim was to investigate the relationship between urinary excretion of deoxypyridinoline (DPD) as a marker of bone resorption, and Perthes' disease. There were 39 children with Perthes' disease in the florid stage who collected first-morning urine samples at regular intervals of at least three months. The level of urinary DPD was analysed by chemiluminescence immunoassay and was correlated with the radiological stage of the disease as classified by Waldenström, and the severity of epiphyseal involvement according to the classification systems of Catterall and Herring. The urinary DPD levels of a group of 44 healthy children were used as a control. The median urinary DPD/creatinine (CREA) ratio was significantly reduced (p < 0.0001) in the condensation stage and increased to slightly elevated values at the final stage (p = 0.05) when compared with that of the control group. Herring-C patients showed significantly lower median DPD/CREA ratios than Herring-B patients (p = 0.03). The significantly decreased median DPD/CREA ratio in early Perthes' disease indicated a reduced bone turnover and supports the theory of a systemic aetiology. Urinary levels of DPD may therefore be used to monitor the course of Perthes' disease.
Related Concept Videos
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management